Cargando…

Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats

Cholestasis is a clinical disorder defined as an impairment of bile flow, and that leads to toxic bile acid (BA) accumulation in hepatocytes. Here, we investigated the hepatoprotective effect of Yinchenhaotang (YCHT), a well-known formulae for the treatment of jaundice and liver disorders, against t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Jingyu, Xie, Guoxiang, Liang, Chungeng, Hu, Yiyang, Zhao, Aihua, Huang, Fengjie, Hu, Ping, Liu, Ping, Jia, Wei, Wang, Xiaoning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482856/ https://www.ncbi.nlm.nih.gov/pubmed/28646179 http://dx.doi.org/10.1038/s41598-017-04536-5

Ejemplares similares

Protective Effect of Brazilian Propolis against Liver Damage with Cholestasis in Rats Treated with α-Naphthylisothiocyanate
por: Nakamura, Tadashi, et al.
Publicado: (2013)

Glycyrrhetinic Acid Protects α-Naphthylisothiocyanate- Induced Cholestasis Through Regulating Transporters, Inflammation and Apoptosis
por: Yan, Miao, et al.
Publicado: (2021)

Danning tablets attenuates α-naphthylisothiocyanate-induced cholestasis by modulating the expression of transporters and metabolic enzymes
por: Ding, Lili, et al.
Publicado: (2014)

Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
por: Wu, Peijie, et al.
Publicado: (2021)

Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters
por: Yi, Ya-Xiong, et al.
Publicado: (2018)

Huangqi Decoction Alleviates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis by Reversing Disordered Bile Acid and Glutathione Homeostasis in Mice
por: Wu, Jia-Sheng, et al.
Publicado: (2017)

Chicken bile powder protects against α-naphthylisothiocyanate-induced cholestatic liver injury in mice
por: Li, Yi-Fei, et al.
Publicado: (2017)

Metabolomic Analysis Reveals the Therapeutic Effects of MBT1805, a Novel Pan-Peroxisome Proliferator-Activated Receptor Agonist, on α-Naphthylisothiocyanate-Induced Cholestasis in Mice
por: Wang, Chang, et al.
Publicado: (2021)

Quercetin 7-rhamnoside protects against alpha-naphthylisothiocyanate (ANIT)-induced in cholestatic hepatitis rats by improving biliary excretion and inhibiting inflammatory responses
por: Jin, Hong-Liu, et al.
Publicado: (2023)

Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis
por: Xie, Guoxiang, et al.
Publicado: (2021)

Oral herbal medicine for women with intrahepatic cholestasis in pregnancy: a systematic review of randomized controlled trials
por: Wang, Ruiting, et al.
Publicado: (2020)

Protective effect of dehydroandrographolide on obstructive cholestasis in bile duct-ligated mice
por: Weng, Zhiyong, et al.
Publicado: (2017)

Towards Polypharmacokinetics: Pharmacokinetics of Multicomponent Drugs and Herbal Medicines Using a Metabolomics Approach
por: Lan, Ke, et al.
Publicado: (2013)

Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure
por: Xie, Guoxiang, et al.
Publicado: (2018)

Saikokeishito Extract Exerts a Therapeutic Effect on α-Naphthylisothiocyanate-Induced Liver Injury in Rats through Attenuation of Enhanced Neutrophil Infiltration and Oxidative Stress in the Liver Tissue
por: Ohta, Yoshiji, et al.
Publicado: (2007)

Protective Effects of Ethanolic Extracts from Artichoke, an Edible Herbal Medicine, against Acute Alcohol-Induced Liver Injury in Mice
por: Tang, Xuchong, et al.
Publicado: (2017)

Activation of autophagy protects against cholestasis-induced hepatic injury
por: Gao, Lu, et al.
Publicado: (2014)

Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes
por: Xie, Guoxiang, et al.
Publicado: (2017)

A Network Pharmacology Study of the Molecular Mechanisms of Hypericum japonicum in the Treatment of Cholestatic Hepatitis with Validation in an Alpha-Naphthylisothiocyanate (ANIT) Hepatotoxicity Rat Model
por: Feng, Sen Ling, et al.
Publicado: (2021)

Pharmacodynamics and Medicinal Chemistry of an External Chinese Herbal Formula for Mammary Precancerous Lesions
por: Chen, Ruixue, et al.
Publicado: (2017)

PPARα: A potential therapeutic target of cholestasis
por: Ye, Xiaoyin, et al.
Publicado: (2022)

Large dose means significant effect – dose and effect relationship of Chi-Dan-Tui-Huang decoction on alpha-naphthylisothiocyanate-induced cholestatic hepatitis in rats
por: Zhao, Yanling, et al.
Publicado: (2015)

Cholestasis in Benign Recurrent Intrahepatic Cholestasis 2
por: Arthur Lorio, Eric, et al.
Publicado: (2020)

Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice
por: Kunst, Roni F., et al.
Publicado: (2022)

Baicalin Protects Against 17α-Ethinylestradiol-Induced Cholestasis via the Sirtuin 1/Hepatic Nuclear Receptor-1α/Farnesoid X Receptor Pathway
por: Yang, Jinyu, et al.
Publicado: (2020)

Factors associated with intrahepatic cholestasis of pregnancy and its influence on maternal and infant outcomes
por: Li, Ping, et al.
Publicado: (2023)

Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease
por: Feng, Qin, et al.
Publicado: (2017)

Chinese herbal medicine research in eczema treatment
por: Hon, Kam Lun, et al.
Publicado: (2011)

HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases
por: Li, Ruo-Lan, et al.
Publicado: (2020)

Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
por: Wang, Jieyi, et al.
Publicado: (2022)

Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations
por: Chen, Tianlu, et al.
Publicado: (2016)

Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis
por: Muchova, Lucie, et al.
Publicado: (2015)

Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Chinmedomics, a new strategy for evaluating the therapeutic efficacy of herbal medicines
por: Han, Ying, et al.
Publicado: (2020)

Quality Control on Herbal Medicine and Its Application
por: Chan, Gallant Kar-Lun, et al.
Publicado: (2018)

Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects
por: Shan, Dan, et al.
Publicado: (2023)

Editorial: Herbal Medicines in Pain Management
por: Hu, Wen-Long, et al.
Publicado: (2022)

Herbal medicines
por: Ghodse, Hamid
Publicado: (2005)

The Scientific Foundation of Chinese Herbal Medicine against COVID-19
por: Leung, Elaine Lai-Han, et al.
Publicado: (2020)

Chinese Herbal Medicine-induced Liver Injury
por: Ma, Xin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_juhglmt65um79naip7i9id1u01